. "2 Thyroid Physiology." Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. Washington, DC: The National Academies Press, 2004.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident
Table 2.7 Risk Groups for Iodine-Induced Hyperthyroidism
Underlying thyroid disease
Iodine supplementation for endemic iodine-deficiency goiter
Iodine administration to patients with euthyroid Graves disease, especially those in remission after antithyroid drug therapy
Nontoxic nodular goiter
Autonomous nodules
Nontoxic diffuse goiter
No underlying thyroid disease
Iodine administration to patients with no recognized underlying thyroid disease, especially in areas of mild to moderate iodine deficiency
Iodine may also be useful in some clinical situations other than a need to prevent iodine deficiency (Table 2.8).
Table 2.8 Medical Uses of Stable Iodine
Treatment and prevention of iodine deficiency goiter
Thyroid storm
Preoperative preparation of toxic goiter
Post 131I therapy of Graves disease
As sole therapy of Graves disease (when sensitive to antithyroid drugs)
